Related Experiment Video
Updated: Jun 10, 2026
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Role of reduced expression of SMAD4 in papillary thyroid carcinoma
Sonia D'Inzeo1, Arianna Nicolussi, Antonella Ricci
1Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, Rome, Italy.
Abstract:
It has been demonstrated that transforming growth factor-β (TGFβ) and other members of TGFβ superfamily play an important role in thyroid proliferative diseases. The deficiencies of SMAD4 are responsible to accelerate the malignant progression of neoplastic lesions in several types of tumors. Therefore, the objective of the present study was to determine the functional role of reduced expression of SMAD4 in human papillary thyroid carcinogenesis. For this purpose, we examined the TGFβ response in two cell lines, TPC-1 and BCPAP. Our data demonstrated for the first time that these cells showed a strong reduction in the level of SMAD4 protein, which was responsible for an alteration of TGFβ signaling and for some of the TGFβ-mediated biological effects. The overexpression of SMAD4, restoring TGFβ transduction, determined a significant increase of antiproliferative response to TGFβ, and reduced the invasive behavior of these cells. Therefore, our data indicated that reduction of SMAD4 may play a significant role in thyroid carcinogenesis.
Insights
Reduced SMAD4 protein levels accelerate malignant progression in thyroid cancer. Restoring SMAD4 enhances anti-proliferative responses and reduces invasion, indicating its significant role in papillary thyroid carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-beta (TGFβ) and its superfamily are implicated in thyroid proliferative diseases.
- SMAD4 deficiencies accelerate malignant progression in various tumors.
Purpose of the Study:
- To investigate the functional role of reduced SMAD4 expression in human papillary thyroid carcinogenesis.
- To analyze the impact of SMAD4 on TGFβ signaling in thyroid cancer cells.
Main Methods:
- Examined TGFβ response in TPC-1 and BCPAP human papillary thyroid cancer cell lines.
- Assessed SMAD4 protein levels and TGFβ signaling.
- Performed SMAD4 overexpression studies.
Main Results:
- TPC-1 and BCPAP cells exhibited significantly reduced SMAD4 protein levels.
- Reduced SMAD4 altered TGFβ signaling and its biological effects.
- SMAD4 overexpression restored TGFβ transduction, increasing anti-proliferative effects and reducing cell invasion.
Conclusions:
- Reduced SMAD4 expression plays a significant role in papillary thyroid carcinogenesis.
- SMAD4 is crucial for proper TGFβ signaling in thyroid cancer.
- Targeting SMAD4 may offer therapeutic strategies for thyroid cancer.
Related Concept Videos
02:23Abnormal Proliferation
01:16TGF - β Signaling Pathway
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...